( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
305.79
232.46
129.29
97.82
Total Expenditure
242.82
163.51
78.05
71.67
PBIDT (Excl OI)
62.97
68.95
51.24
26.15
Other Income
7.13
0.63
0.88
0.51
Operating Profit
70.1
69.58
52.12
26.66
Exceptional Items
NA
NA
NA
NA
Depreciation
15.06
13.3
9
8.98
Profit Before Tax
46.86
50.3
40.31
16.04
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
48.26
37.07
28.77
13.33
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
48.26
37.07
28.77
13.33
Minority Interest
2.16
-7.65
-2.08
-0.55
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
50.42
29.42
26.69
12.78
Equity Capital
157.69
157.69
113.69
113.69
Calculated EPS
0.63
0.37
0.46
0.22
Calculated EPS (Annualised)
2.55
1.49
1.87
0.89
No of Public Share Holdings
22509350
22509350
22509350
NA
% of Public Share Holdings
28.55
28.55
28.55
NA
PBIDTM% (Excl OI)
20.59
29.66
39.63
26.73
PBIDTM%
22.92
29.93
40.31
27.25
PBDTM%
20.24
27.35
38.13
25.57
PBTM%
15.32
21.63
31.17
16.39
PATM%
15.78
15.94
22.25
13.62